Biomarkers of Brain Injury in Children-Potentia Uses and Limitations: S100B, NSE, GFAP, NF-H, secretagogin and Hsp70

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F11%3A00052047" target="_blank" >RIV/00216224:14110/11:00052047 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Biomarkers of Brain Injury in Children-Potentia Uses and Limitations: S100B, NSE, GFAP, NF-H, secretagogin and Hsp70

Original language description

Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Clinical examination has limited ability to assess injury severity or predict outcome. The identification of pathology- specific biomarkers can assist in the diagnosis andestimation of prognosis, and can serve as surrogate markers for monitoring the effectiveness of a treatment. Most of these biomarkers are mediators of responses to injury and subsequent cell damage or cell death. For patients with severe TBI, a biomarker may be helpful to predict which patients are likely to experience secondary insults and help prognosticate. The aims of this study were the correlations amongs biomarkers of brain injury in children with severity of brain injury, mortality and prediction of the final outcome.

Czech name

—

Czech description

—

Type

B - Specialist book

CEP classification

FP - Other medical fields

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2011

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

ISBN

978-3-8443-1180-8

Number of pages

120

Publisher name

LAP LAMBERT

Place of publication

Saarbrücken (Germany)

UT code for WoS book

—